Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Hospital of Philadelphia
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
NYU Langone Health
Dana-Farber Cancer Institute
Universitätsklinikum Hamburg-Eppendorf
Barbara Ann Karmanos Cancer Institute
St. Jude Children's Research Hospital